Phase I of XKH002 Injection in Patients
NCT06196762
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced or Metastatic Solid Tumors
Interventions
DRUG:
XKH002 Injection
Sponsor
Zhejiang Kanova Biopharmaceutical Co., LTD